Evrofarma: 53% increase in net profits during first half of 2020

0
Evrofarma - Increase in net profits

Evrofarma, an innovative Greek dairy company based in Thrace, northern Greece, has recently published the financial results for the period which ended June 30, 2020.
Namely, the company’s consolidated turnover amounted to €15,675 thousand compared to €17,466 thousand, showing a 10% decrease, while the corporate turnover amounted to €13,237 thousand compared to €15,075 thousand over the period covered, showing a 12% decrease. The decrease is mainly due to the effect of the restrictive measures taken by Greece to deal with the spread of the COVID-19 pandemic.
The gross consolidated margin stood at 20.42% against 21.84% and the corporate margin at 20.34% compared to 21.31% of the previous comparative period. In absolute terms, gross profit amounted to €3,201 thousand and €2,692 thousand compared to €3,814 thousand and €3,212 thousand for the consolidated and corporate level, respectively.
Earnings before interest, taxes, depreciation and depreciation (EBITDA) amounted to €1,454 thousand and €883 thousand for the Evrofarma group and the company respectively, compared to €2,191 thousand and €1,557 thousand for comparative information, reduced by 33.63% and 43.28% respectively.
Consolidated before tax profits amounted to €429 thousand against €537 thousand, reduced by 20.1% and corporate profits amounted to €25 thousand against €20 thousand.
Consolidated after tax profits amounted to €338 thousand against €221 thousand, showing an increase of 52.94%. Respectively, the company’s after tax profits amounted to €24 thousand against €167 thousand in losses for the comparative period.

READ MORE: Entrepreneurship